1. Be able to define what is Low Risk thyroid cancer.
2. Be able to discuss the literature supporting Watchful Wait (Active Surveillance) and Treatment (Why Wait)
3. Be able to recognize the clinical challenges resulting from ATA 2015 Guidelines and impact on population and patient management.
4. Be able to plan and deliver patient specific thyroid cancer treatment which may include radioiodine therapy.